Evidence map›Paper›PMID 39874225›Full record

ArticleAnnals of the rheumatic diseases2025

Comparison of definitions of early knee osteoarthritis for likelihood of progression at 2-year and 5-year follow-up: the Multicenter Osteoarthritis Study.

Jean W Liew, Eva Petrow, Sarah Tilley, Michael P LaValley, Frank W Roemer, Ali Guermazi, Cora E Lewis, James Torner, Michael C Nevitt, John A Lynch and 1 more

Abstract readMulticenter StudyComparative Study
In one paragraph

Article in Annals of the rheumatic diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jean W LiewBoston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA. Electronic address: jwliew@bu.edu.
Eva PetrowBoston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
Sarah TilleyBoston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
Michael P LaValleyBiostatistics, School of Public Health, Boston, Massachusetts, USA.
Frank W RoemerRadiology, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA; Department of Radiology, Friedrich Alexander University Erlangen Nuremberg Faculty of Medicine, Erlangen, Bayern, Germany.
Ali GuermaziBoston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA; Radiology, VA Boston Healthcare System, West Roxbury, Massachusetts, USA.
Cora E LewisThe University of Alabama at Birmingham, Birmingham, Alabama, USA.
James TornerEpidemiology, University of Iowa, Iowa, Iowa, USA.
Michael C NevittUniversity of California San Francisco, San Francisco, California, USA.
John A LynchUniversity of California San Francisco, San Francisco, California, USA.
David FelsonBoston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA. Electronic address: https://twitter.com/david_felson.

Funding

Project 3: Intraarticular MineralizationU19AG076471 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI TUHINA NEOGI · 2023 to 2026
$49.0M
Multicenter Osteoarthritis Study (MOST) Second RenewalU01AG019069 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NEVITT, MICHAEL C · 2001 to 2020
$21.7M
Multicenter Osteoarthritis Study (MOST) Second Renewal: Iowa Clinical CenterU01AG018832 · NIA · UNIVERSITY OF IOWA · PI SEGAL, NEIL A, TORNER, JAMES C · 2001 to 2020
$14.1M
Multicenter Osteoarthritis Study (MOST) Second Renewal - Boston UniversityU01AG018820 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FELSON, DAVID TOBIN · 2001 to 2019
$13.6M
Multicenter Osteoarthritis Study (MOST) Second Renewal - UAB Clinical CenterU01AG018947 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LEWIS, CORA E · 2001 to 2020
$13.2M
Research and Evaluation Support Core Unit (RESCU Core)P30AR072571 · NIAMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Michael Paul Lavalley · 2019 to 2026
$6.9M
The role of vitamin K in knee osteoarthritis outcomesK23AR082938 · NIAMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Jean Wai Liew · 2024 to 2026
$518k
NIAMS NIH HHS K23 AR082938NIAMS NIH HHS P30 AR072571NIA NIH HHS U01 AG018820NIA NIH HHS U01 AG018832NIA NIH HHS U01 AG018947NIA NIH HHS U01 AG019069NIA NIH HHS U19 AG076471
6 · The paper itself

Abstract

backgroundPreventing worsening osteoarthritis (OA) in persons with early OA is a major treatment goal. We evaluated if different early OA definitions yielded enough cases of worsening OA within 2-5 years to make trial testing treatments feasible.

methodsWe assessed different definitions of early OA using data from Multicenter Osteoarthritis (MOST) Study participants who were followed up longitudinally. We defined early OA as having at least minimal knee pain (WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) pain ≥3/20) with different levels of pre-radiographic OA. For MRI, we required knee pain and used MRI definitions with combinations of cartilage damage, osteophytes, bone marrow lesions and meniscus damage. The primary outcome, worsening OA at 2 or 5 years, combined structural (Kellgren and Lawrence grade ≥2 with joint space narrowing ≥1) and symptom (WOMAC pain ≥6 with increase ≥2 from baseline) outcomes. We also examined structural and symptom outcomes separately.

resultsFor worsening OA at 2 years, we included 750 participants (mean age 65 years, 60% female, 90% white, mean body mass index 29.2 kg/m

conclusionMost knees with early OA are stable and do not progress. Some painful knees experience worse pain but not structural progression and vice versa. Trial testing treatments to prevent OA illness or disease will be challenging.

Indexed as

Osteoarthritis, KneeAgedCartilage, ArticularDisease ProgressionFemaleFollow-Up StudiesHumansKnee JointLongitudinal StudiesMagnetic Resonance ImagingMaleMiddle AgedOsteophytePain MeasurementSeverity of Illness IndexClassificationKneeMagnetic Resonance ImagingOsteoarthritis

Identifiers

PMID39874225
PMCPMC11868720

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.